Patents by Inventor Georges Lutfalla

Georges Lutfalla has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6475983
    Abstract: Water-soluble polypeptides having high affinity for interferons &agr; and &bgr;; DNA sequences and expression cells; a preparation method therefor; drugs; compositions containing same; and uses thereof as a diagnostic agent or for producing antibodies.
    Type: Grant
    Filed: February 17, 1993
    Date of Patent: November 5, 2002
    Assignee: Medisup International N.V.
    Inventors: Pierre Eid, Ion Gresser, Georges Lutfalla, Francois Meyer, Knud Erik Mogensen, Michael Tovey, Gilles Uze
  • Patent number: 5889151
    Abstract: The subject invention relates to a purified receptor of human alpha interferon.
    Type: Grant
    Filed: May 30, 1995
    Date of Patent: March 30, 1999
    Assignee: Societe Leb-Tech
    Inventors: Knud Erik Mogensen, Gilles Uze, Georges Lutfalla, Ion Gresser
  • Patent number: 5886153
    Abstract: The present invention relates to antibodies against an alpha interferon receptor, as well as to kits comprising such antibodies. The antibodies of the invention are suitable for the assay of the receptors or for their visualization in the case of imaging. The present antibodies and kits can thus be used as diagnostics or imaging agents, or as pharmacological models to test compounds derived from human alpha interferon.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: March 23, 1999
    Assignee: Societe LEB-TECH
    Inventors: Knud Erik Mogensen, Gilles Uze, Georges Lutfalla, Ion Gresser
  • Patent number: 5861258
    Abstract: The invention relates to the use of the human alpha interferon receptor and of non human host cells which express said receptor, to identify alpha interferon agonists.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: January 19, 1999
    Assignee: Societe LEB-TECH
    Inventors: Knud Erik Mogensen, Gilles Uze, Georges Lutfalla, Ion Gresser
  • Patent number: 5763166
    Abstract: The invention relates to a fragment of nucleic acid characterized in that it comprises a nucleotide sequence selected from: (A) the sequence SEQ ID No. 1; (B) the sequences of one or more bases; (C) fragments of the said sequences (A) and (B); (D) sequences complementary to the said sequences (A), (B), and (C); and (E) the sequences which hybridize with the sequences (A),(B), and (C). The corresponding peptide sequences are also disclosed. A nucleic acid fragment of the invention may be used as a primer or probe, particularly in a method for diagnosing a genetic anomaly linked to the Kallmann syndrome.
    Type: Grant
    Filed: June 30, 1994
    Date of Patent: June 9, 1998
    Assignees: Institut Pasteur, The United States of America as represented by the Department of Health and Human Services
    Inventors: Christine Petit, Jean-Michel Claverie, Jacuqeline Levilliers, Renaud Legouis, Jean-Pierre Hardelin, Georges Lutfalla
  • Patent number: 5731169
    Abstract: The invention relates to the human alpha interferon receptor and to the DNA sequence, including the cDNA sequence, encoding the receptor. The invention also relates to non-human cells which express said receptor, to a process for obtaining said cells, and to a process for the preparation of the receptor.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: March 24, 1998
    Assignee: Societe Leb-Tech
    Inventors: Knud Erik Mogensen, Gilles Uze, Georges Lutfalla, Ion Gresser